Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

NCT06363760 is registered in ClinicalTrials.gov with Editas Medicine, Inc. as lead sponsor.

NCT NCT06363760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06363760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301
Lead sponsor
Editas Medicine, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 17, 2024
Completion date
August 31, 2040
Enrollment
54 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hemoglobinopathies, sickle cell disease, transfusion-dependent beta-thalassemia